×
0 0 0.0392011834319526 0.0724852071005916 0.0835798816568046 -0.0125739644970414 0.00147928994082837 0.00147928994082837
Stockreport

Akebia Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results

AKEBIA THERAPEUTICS (AKBA)  More Company Research Source: Business Wire
Last akebia therapeutics earnings: 8/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF --Company to Host Conference Call Today at 4:30 p.m. Eastern Time-- CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced financial results for the fourth quarter and full year ended December 31, 2017. “The past year was highly productive for Akebia as we advanced our global Phase 3 program for vadadustat and completed significant collaboration and licensing deals to provide us with R&D financing, stronger commercial presence at launch and significant validation of vadadustat,” said John P. Butler, President and Chief Executive Officer of Akebia Therapeutics. “We are now approaching an important inflection point, with top-line Phase 3 results anticipated next year, subject to the accrual of MACE ev [Read more]

IMPACT SNAPSHOT EVENT TIME: AKBA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKBA alerts

from News Quantified
Opt-in for
AKBA alerts

from News Quantified